After extensive research over the past few years, hepatokine FGF-21 has emerged as a promising diagnostic marker for an accurate and non-invasive diagnosis of NAFLD [24,25]. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.